U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Lidocaine Hydrochloride Injection
Status: Discontinuation
»Therapeutic Categories: Anesthesia; Pediatric

Expand all

Afaxys Pharma (Revised 03/05/2025)

Company Contact Information:
713-724-0238

Presentation Posting Date Related Information
Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 50102-400-10) 03/05/2025

Hospira, Inc., a Pfizer Company (New 11/07/2025)

Company Contact Information:
844-646-4398

Presentation Posting Date Related Information
Lidocaine Hydrochloride, Injection, 2%, USP (For Cardiac Use Only) 100 mg/5 mL (20 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2") (NDC 0409-4903-34) 11/07/2025 Discontinuation of the manufacture of the drug
Lidocaine Hydrochloride, Injection, 1%, USP (For Cardiac Use Only) 50 mg/5 mL (10 mg/mL) LifeShield™ ABBOJECT® Glass Syringe (20 G x 1 1/2") (NDC 0409-4904-34) 11/07/2025 Discontinuation of the manufacture of the drug
Back to Top